Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Comparative DNA methylomic analyses reveal potential origins of novel epigenetic biomarkers of insulin resistance in monocytes from virally suppressed HIV-infected adults.

Dye CK, Corley MJ, Li D, Khadka VS, Mitchell BI, Sultana R, Lum-Jones A, Shikuma CM, Ndhlovu LC, Maunakea AK.

Clin Epigenetics. 2019 Jun 28;11(1):95. doi: 10.1186/s13148-019-0694-1.

2.

Juvenile Shank3b deficient mice present with behavioral phenotype relevant to autism spectrum disorder.

Balaan C, Corley MJ, Eulalio T, Leite-Ahyo K, Pang APS, Fang R, Khadka VS, Maunakea AK, Ward MA.

Behav Brain Res. 2019 Jan 1;356:137-147. doi: 10.1016/j.bbr.2018.08.005. Epub 2018 Aug 19.

3.

A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder.

Lee RWY, Corley MJ, Pang A, Arakaki G, Abbott L, Nishimoto M, Miyamoto R, Lee E, Yamamoto S, Maunakea AK, Lum-Jones A, Wong M.

Physiol Behav. 2018 May 1;188:205-211. doi: 10.1016/j.physbeh.2018.02.006. Epub 2018 Feb 5. No abstract available.

4.

Comparative DNA Methylation Profiling Reveals an Immunoepigenetic Signature of HIV-related Cognitive Impairment.

Corley MJ, Dye C, D'Antoni ML, Byron MM, Yo KL, Lum-Jones A, Nakamoto B, Valcour V, SahBandar I, Shikuma CM, Ndhlovu LC, Maunakea AK.

Sci Rep. 2016 Sep 15;6:33310. doi: 10.1038/srep33310.

5.

High-throughput sequencing offers new insights into 5-hydroxymethylcytosine.

Pang AP, Sugai C, Maunakea AK.

Biomol Concepts. 2016 Jun 1;7(3):169-78. doi: 10.1515/bmc-2016-0011. Review.

6.

A mutation in the tuft mouse disrupts TET1 activity and alters the expression of genes that are crucial for neural tube closure.

Fong KS, Hufnagel RB, Khadka VS, Corley MJ, Maunakea AK, Fogelgren B, Ahmed ZM, Lozanoff S.

Dis Model Mech. 2016 May 1;9(5):585-96. doi: 10.1242/dmm.024109. Epub 2016 Mar 17.

7.

Community-Based Participatory Research Integrates Behavioral and Biological Research to Achieve Health Equity for Native Hawaiians.

Townsend CK, Dillard A, Hosoda KK, Maskarinec GG, Maunakea AK, Yoshimura SR, Hughes C, Palakiko DM, Kehauoha BP, Kaholokula JK.

Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010004. doi: 10.3390/ijerph13010004.

8.

Semiconductor-based sequencing of genome-wide DNA methylation states.

Corley MJ, Zhang W, Zheng X, Lum-Jones A, Maunakea AK.

Epigenetics. 2015;10(2):153-66. doi: 10.1080/15592294.2014.1003747.

9.

Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition.

Maunakea AK, Chepelev I, Cui K, Zhao K.

Cell Res. 2013 Nov;23(11):1256-69. doi: 10.1038/cr.2013.110. Epub 2013 Aug 13.

10.

Methylation of histone H3 on lysine 79 associates with a group of replication origins and helps limit DNA replication once per cell cycle.

Fu H, Maunakea AK, Martin MM, Huang L, Zhang Y, Ryan M, Kim R, Lin CM, Zhao K, Aladjem MI.

PLoS Genet. 2013 Jun;9(6):e1003542. doi: 10.1371/journal.pgen.1003542. Epub 2013 Jun 6. Erratum in: PLoS Genet. 2013 Jul;;9(7). doi:10.1371/annotation/2b2d77ee-6d39-4685-b2e5-ebba0b793902.

11.

Epigenome mapping in normal and disease States.

Maunakea AK, Chepelev I, Zhao K.

Circ Res. 2010 Aug 6;107(3):327-39. doi: 10.1161/CIRCRESAHA.110.222463. Review.

12.

Conserved role of intragenic DNA methylation in regulating alternative promoters.

Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, Heine VM, Rowitch DH, Xing X, Fiore C, Schillebeeckx M, Jones SJ, Haussler D, Marra MA, Hirst M, Wang T, Costello JF.

Nature. 2010 Jul 8;466(7303):253-7. doi: 10.1038/nature09165.

13.

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG.

BMC Med. 2008 Jun 24;6:14. doi: 10.1186/1741-7015-6-14.

14.

Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells.

Reinhold WC, Reimers MA, Maunakea AK, Kim S, Lababidi S, Scherf U, Shankavaram UT, Ziegler MS, Stewart C, Kouros-Mehr H, Cui H, Dolginow D, Scudiero DA, Pommier YG, Munroe DJ, Feinberg AP, Weinstein JN.

Mol Cancer Ther. 2007 Feb;6(2):391-403. Epub 2007 Feb 1.

15.

Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3.

Ching TT, Maunakea AK, Jun P, Hong C, Zardo G, Pinkel D, Albertson DG, Fridlyand J, Mao JH, Shchors K, Weiss WA, Costello JF.

Nat Genet. 2005 Jun;37(6):645-51. Epub 2005 May 15.

PMID:
15895082
16.

Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.

Reinhold WC, Kouros-Mehr H, Kohn KW, Maunakea AK, Lababidi S, Roschke A, Stover K, Alexander J, Pantazis P, Miller L, Liu E, Kirsch IR, Urasaki Y, Pommier Y, Weinstein JN.

Cancer Res. 2003 Mar 1;63(5):1000-11.

Supplemental Content

Loading ...
Support Center